畜牧兽医学报 ›› 2025, Vol. 56 ›› Issue (8): 3958-3966.doi: 10.11843/j.issn.0366-6964.2025.08.033

• 预防兽医 • 上一篇    下一篇

B亚型禽偏肺病毒病弱毒疫苗对商品蛋鸡的免疫效果

薛晓晓1,2(), 孟令宅2, 王素艳2, 于蒙蒙2, 陈运通2, 祁小乐2, 李留安1, 于晓雪1,*(), 高玉龙2,*()   

  1. 1. 天津农学院动物科学与动物医学学院 天津市农业动物繁育与健康养殖重点实验室, 天津 300392
    2. 中国农业科学院哈尔滨兽医研究所 动物疫病防控全国重点实验室 禽免疫抑制病创新团队, 哈尔滨 150069
  • 收稿日期:2024-10-30 出版日期:2025-08-23 发布日期:2025-08-28
  • 通讯作者: 于晓雪,高玉龙 E-mail:1213273476@qq.com;yuxiaoxue1990@163.com;gaoyulong@caas.cn
  • 作者简介:薛晓晓(1993-),女,河北邯郸人,硕士生,主要从事禽免疫抑制病研究,E-mail:1213273476@qq.com
  • 基金资助:
    国家重点研发计划资助项目(2023YFE0106100);国家肉鸡产业技术体系项目(CARS-41)

Study on Immune Effect of Subtype B Attenuated Avian Metapneumovirus Disease Vaccine on Commercial Layer Chickens

XUE Xiaoxiao1,2(), MENG Lingzhai2, WANG Suyan2, YU Mengmeng2, CHEN Yuntong2, QI Xiaole2, LI Liuan1, YU Xiaoxue1,*(), GAO Yulong2,*()   

  1. 1. Tianjin Key Laboratory of Agricultural Animal Breeding and Healthy Husbandry, College of Animal Science and Veterinary Medicine, Tianjin Agricultural University, Tianjin 300392, China
    2. Avian Immunosuppressive Disease Division, State Key Laboratory for Animal Disease Control and Prevention, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin 150069, China
  • Received:2024-10-30 Online:2025-08-23 Published:2025-08-28
  • Contact: YU Xiaoxue, GAO Yulong E-mail:1213273476@qq.com;yuxiaoxue1990@163.com;gaoyulong@caas.cn

摘要:

为评价B亚型禽偏肺病毒病弱毒疫苗对商品蛋鸡免疫保护效果,本研究用实验室前期制备的B亚型禽偏肺病毒病弱毒疫苗(LN16-A株),通过滴鼻方式以400 TCID50 ·只-1的剂量接种21日龄的商品蛋鸡。免疫后7、14和21 d分别采血分离血清,测定ELISA抗体和中和抗体效价,结果显示,免疫后21 d免疫组血清抗体阳性率为90%,中和抗体平均效价为7.51 log2。免疫后21 d,使用B亚型禽偏肺病毒强毒(LN16-V株)进行攻毒保护评价,攻毒剂量为5 000 TCID50 ·只-1,结果显示,攻毒对照组鸡出现混浊或黏稠样鼻涕,发病率为80%,免疫组鸡均未发病;采用RT-qPCR方法测定各组鸡1~7 d腭裂拭子中的病毒拷贝数,结果显示,免疫组病毒载量仅为攻毒对照组的1/100;组织病理学结果显示,攻毒对照组鸡的鼻甲骨及气管等组织出现不同程度的病理损伤,而免疫组鸡均未出现任何病理变化。以上结果表明, B亚型禽偏肺病毒病弱毒疫苗(LN16-A株)对商品蛋鸡具有良好的免疫保护效果。本研究为控制蛋鸡群B亚型禽偏肺病毒的流行和制定预防B亚型禽偏肺病的免疫程序提供了理论依据。

关键词: B亚型禽偏肺病毒, 弱毒疫苗, 商品蛋鸡, 免疫效果

Abstract:

To evaluate the protective efficacy of the attenuated vaccine against subtype B avian metapneumovirus on commercial layer chickens, the attenuated vaccine against subtype B avian metapneumovirus (LN16-A strain) prepared in the laboratory was used to immunize 21-day-old commercial layer chickens by intranasal administration at a dose of 400 TCID50/chicken. Samples were collected on 7, 14, and 21 days post-immunization to separate the serum and measure the ELISA antibody and neutralizing antibody titers. At 21 days after immunization, the results showed the positive rate of ELISA antibody was 90% and the average neutralizing antibody titer was 7.51 log2 in the immunization group. At 21 days post-immunization, the commercial layer chickens were attacked by subtype B avian metapneumovirus (LN16-V strain) at a dose of 5 000 TCID50 per chicken. The results indicated that chickens in the challenge control group had cloudy or viscous nose with an 80% incidence rate, while chickens in the immune group showed no clinical symptoms. RT-qPCR was used to measure virus copies in palatine swabs collected from chickens in each group from 1 to 7 days. The results showed that the viral loads in the immune group decreased by 175 folds compared with that in the challenge control group. And the histopathological examination results showed that varying degrees of pathological damage in tissues such as the turbinate bone and trachea of chickens were found in the challenge control group, while no obvious pathological changes of chickens were found in the immune group. The above results indicate that the attenuated vaccine against subtype B avian metapneumovirus (LN16-A strain) can provide protection for commercial layer chickens. And this study further provides a theoretical basis for controlling the prevalence of subtype B avian metapneumovirus in layer flocks and formulating an immunization program to prevent subtype B avian metapneumovirus disease.

Key words: subtype B avian metapneumovirus, attenuated vaccine, commercial layer chickens, immune effect

中图分类号: